Vetter Marks the Start of New Clinical Site Con­struction with Ground­breaking Ceremony

Vetter continues to expand in the US

01-Jul-2025
Vetter Pharma International GmbH

Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony. Participants from left to right: Tom Kikta, Wolfgang Kerkhoff, Gunther Strothe, Dr. Susanne Lemaine, Senator h. c. Udo J. Vetter, Andrew Goczkowski, Thomas Otto, Thomas Rübekeil, Henryk Badack, RT Evans.

Vetter celebrated the start of construction on its new clinical manufacturing site in the Chicago area with an official groundbreaking ceremony. The state-of-the-art facility, which is being built in Des Plaines, Illinois, is expected to be ready for media fill by the end of 2029. This $285 million investment will strengthen Vetter’s position as a leading global partner for aseptic manufacturing in early clinical development.

The new site provides additional capacity for small-batch production of novel active ingredients and includes space for warehouses, laboratories, and administrative offices. The approximately 860,000 square feet site has the capacity to accommodate future expansion, contingent on global demand and additional strategic investments.

"This project marks another milestone in our international growth strategy. It underscores our commitment to quality and innovation, as well as our responsibility to our customers, partners, and patients around the world," Senator h.c. Udo J. Vetter, Chairman of the Advisory Board.

With its new location, Vetter is strengthening its presence in the North American market and supplementing its existing clinical network in Skokie, Illinois and Rankweil, Austria.

Other news from the department manufacturing

Most read news

More news from our other portals

All autoclave manufacturers at a glance

Last viewed contents

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany - First product chambers in the “Factory of the Future”

GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany - First product chambers in the “Factory of the Future”

PL BioScience Announces Major Site Expansion - New 1,200 m² facility in Aachen expands headquarters to support company growth and
scale Human Platelet Lysate production

PL BioScience Announces Major Site Expansion - New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

Commission launches new strategy to make Europe a global leader in life sciences by 2030

Commission launches new strategy to make Europe a global leader in life sciences by 2030

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

Time out: We all need a three-day weekend - Researchers confirm health benefits

Time out: We all need a three-day weekend - Researchers confirm health benefits

Ibidi Awarded With the German bAV Prize 2023

Ibidi Awarded With the German bAV Prize 2023

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

2025 Future Insight Prize Awarded to Helmholtz Center’s Magdalena Götz for Breakthroughs in Brain Regeneration

2025 Future Insight Prize Awarded to Helmholtz Center’s Magdalena Götz for Breakthroughs in Brain Regeneration